8-K: Bausch + Lomb Launches $600 Million Senior Secured Notes Offering and Refinances Credit Agreement

Bausch + Lomb Corporation announced a $600 million senior secured floating rate notes offering and a partial refinancing of its credit agreement, including new term B and revolving credit facilities, to repay existing debt and for general corporate purposes.

Summary

• Bausch + Lomb Corporation's subsidiaries, Bausch & Lomb Incorporated and Bausch+Lomb Netherlands B.V., launched an offering of $600 million aggregate principal amount of senior secured floating rate notes.
• Concurrently with the Notes offering, Bausch + Lomb launched a partial refinancing of its credit agreement.
• This refinancing includes the intent to obtain a new $2.2 billion term B loan facility and a new $800 million revolving credit facility.
• The net proceeds from the Notes offering and the New Term B Loan Facility, combined with borrowings under the New Revolving Credit Facility, are intended to repay certain outstanding borrowings under the existing revolving credit facility.
• The funds will also be used to refinance in full outstanding term A loans due 2027 and term B loans due 2027.
• Any remaining amounts from these transactions will be used for general corporate purposes and to pay related fees and expenses.
• The closing of the Notes offering is not contingent upon the closing of the New Term B Loan Facility or the New Revolving Credit Facility.
• The Notes will be guaranteed by Bausch + Lomb and its non-issuer subsidiaries that are guarantors under its credit agreement, and will be secured on a first priority basis by liens on the same assets that secure obligations under its credit agreement and 8.375% senior secured notes due 2028.

Sentiment

Score: 7

Explanation: The announcement details a proactive financial management step to refinance existing debt and secure new credit facilities, which is generally positive for financial flexibility. The explicit risk of non-completion is a standard disclaimer for such transactions and does not significantly detract from the overall positive intent.

Positives

• The refinancing aims to repay existing term A and term B loans due 2027, potentially optimizing the company's debt maturity profile.
• The establishment of a new $2.2 billion Term B Loan Facility and an $800 million Revolving Credit Facility provides Bausch + Lomb with enhanced financial flexibility and liquidity.
• The use of remaining proceeds for general corporate purposes allows for strategic allocation of capital.

Negatives

• There is no assurance that Bausch + Lomb will be able to successfully complete the described transactions on the stated terms, or at all, as they are subject to market and other conditions.

Risks

• The successful completion of the Notes offering and the credit agreement refinancing is subject to market and other conditions, and there is no guarantee that Bausch + Lomb will be able to complete these transactions on the terms described or at all.
• The Notes will not be registered under the Securities Act of 1933 or any state securities laws, meaning they may only be offered or sold in the United States to qualified institutional buyers and outside the United States to non-U.S. persons, which could limit their marketability.
• The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws, restricting their offer and sale in Canada to exempt bases.

Future Outlook

Bausch + Lomb intends to use the proceeds from the Notes offering and the New Term B Loan Facility, along with borrowings under the New Revolving Credit Facility, to repay existing debt and for general corporate purposes. However, the completion of these transactions is subject to market and other conditions, and there is no assurance that they will be successfully completed on the described terms or at all.

Industry Context

This announcement reflects Bausch + Lomb's proactive management of its capital structure through debt refinancing and new debt issuance. Such financial maneuvers are common for large, established companies in the eye health and pharmaceutical sectors, aiming to optimize debt maturities, interest costs, and overall financial flexibility in response to market conditions and strategic needs.

Stakeholder Impact

• Shareholders: Potential positive impact from improved debt maturity profile and enhanced financial flexibility, though the ultimate impact depends on the terms and cost of the new debt.
• Creditors: Existing creditors holding term A and B loans due 2027 will be repaid. New creditors will acquire the senior secured notes and participate in the new term B loan facility.

Next Steps

• Completion of the $600 million senior secured floating rate notes offering.
• Closing of the $2.2 billion New Term B Loan Facility.
• Closing of the $800 million New Revolving Credit Facility.
• Repayment of certain outstanding borrowings under the existing revolving credit facility.
• Refinancing in full of outstanding term A loans due 2027 and term B loans due 2027.
• Payment of related fees and expenses.
• Use of any remaining amounts for general corporate purposes.

Key Dates

Recommendation

Keywords

Bausch + Lomb, BHC, BLCO, Senior Secured Notes, Debt Offering, Refinancing, Credit Agreement, Term Loan, Revolving Credit Facility, Corporate Finance, Eye Health, Pharmaceuticals, Medical Devices